STADA Arzneimittel AG – Strategy, SWOT and Corporate Finance Report

STADA Arzneimittel AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

STADA Arzneimittel AG (STADA or "the company"), a subsidiary of Nidda Healthcare GmbH is a provider of pharmaceuticals, generics, and biosimilar products. The company develops and markets drugs with off-patent active pharmaceutical ingredients. It offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. STADA major generic products include including Tilidin Naloxon, Pantoprazole, Omeprazole, Diclofenac, Amlodipine, Bisoprolol, Olmesartan, Atorvastatin and Epoetin zeta. It also products for cough and cold, skin products, and treatments for head lice, dandruff, sun protection, mounth inflammation, wound healing. The company’s major branded products include Grippostad, SNUP, Aqualor, Vitaprost, Nizoral, Ladival and Covonia. STADA operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. The company is headquartered in Bad Vilbel, Germany.

Scope

– Detailed information on STADA Arzneimittel AG required for business and competitor intelligence needs

– A study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis

– An in-depth view of the business model of STADA Arzneimittel AG including a breakdown and examination of key business segments

– Intelligence on STADA Arzneimittel AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about STADA Arzneimittel AG, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of STADA Arzneimittel AG and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess STADA Arzneimittel AG as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on STADA Arzneimittel AG's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

STADA Arzneimittel AG: Company Overview

STADA Arzneimittel AG: Overview and Key Facts

STADA Arzneimittel AG: Overview

STADA Arzneimittel AG: Key Facts

STADA Arzneimittel AG: Key Employees

STADA Arzneimittel AG: Key Employee Biographies

STADA Arzneimittel AG: Major Products and Services

STADA Arzneimittel AG: Locations and Subsidiaries

STADA Arzneimittel AG: Key Competitors

STADA Arzneimittel AG: Company Analysis

STADA Arzneimittel AG: Business Description

STADA Arzneimittel AG: SWOT Analysis

STADA Arzneimittel AG: SWOT Overview

STADA Arzneimittel AG: Strengths

STADA Arzneimittel AG: Weaknesses

STADA Arzneimittel AG: Opportunities

STADA Arzneimittel AG: Threats

STADA Arzneimittel AG: Corporate Financial Deals Activity

STADA Arzneimittel AG: Financial Deals Overview

STADA Arzneimittel AG: Targets and Partners

STADA Arzneimittel AG: Top Deals 2019 - 2023YTD*

STADA Arzneimittel AG: Advisors

STADA Arzneimittel AG: Top Legal Advisors

STADA Arzneimittel AG: Top Financial Advisors

STADA Arzneimittel AG: Mergers and Acquisitions

STADA Arzneimittel AG: Partnership

STADA Arzneimittel AG: Divestments

STADA Arzneimittel AG: Recent Developments

STADA Arzneimittel AG: News and Events Summary

STADA Arzneimittel AG: Corporate Governance

STADA Arzneimittel AG: Financial Deals

STADA Arzneimittel AG: Financial Performance

STADA Arzneimittel AG: Research & Development

STADA Arzneimittel AG: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: STADA Arzneimittel AG: Key Facts

Table 2: STADA Arzneimittel AG: Key Employees

Table 3: STADA Arzneimittel AG: Locations and Subsidiaries

Table 4: STADA Arzneimittel AG: Key Competitors

Table 5: STADA Arzneimittel AG: Deal Activity by Deal Type – Volume (TTM*)

Table 6: STADA Arzneimittel AG: Deal Activity by Deal Type – Volume (2019 – YTD*2023)

Table 7: STADA Arzneimittel AG: M&A Average Deal Size – Value (US$m)

Table 8: STADA Arzneimittel AG: Targets and Partners

Table 9: STADA Arzneimittel AG: Top Deals 2019 – 2023YTD*

Table 10: STADA Arzneimittel AG: Legal Advisor Ranking by Value (US$m)

Table 11: STADA Arzneimittel AG: Financial Advisor Ranking by Value (US$m)

Table 12: STADA Arzneimittel AG: M&A Volume and Value Trend (2019 – YTD*2023)

Table 13: STADA Arzneimittel AG: M&A Activity by Geography (2019 – YTD*2023)

Table 14: STADA Arzneimittel AG: Partnership Volume and Value Trend (2019 – YTD*2023)

Table 15: STADA Arzneimittel AG: Partnership Trend by Deal Type (2019 – YTD*2023)

Table 16: STADA Arzneimittel AG: Divestments Volume and Value Trend (2019 – YTD*2023)

Table 17: STADA Arzneimittel AG: News and Events Summary

Table 18: STADA Arzneimittel AG: Corporate Governance

Table 19: STADA Arzneimittel AG: Financial Deals

Table 20: STADA Arzneimittel AG: Financial Performance

Table 21: STADA Arzneimittel AG: Research & Development

Table 22: STADA Arzneimittel AG: Strategy and Operations

List of Figures

List of Figures

Figure 1: STADA Arzneimittel AG: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: STADA Arzneimittel AG: Deal Activity by Deal Type – Volume (2019 – YTD*2023)

Figure 3: STADA Arzneimittel AG: M&A Average Deal Size – Value (US$m)

Figure 4: STADA Arzneimittel AG: M&A Volume and Value Trend (2019 – YTD*2023)

Figure 5: STADA Arzneimittel AG: M&A Activity by Geography (2019 – YTD*2023)

Figure 6: STADA Arzneimittel AG: Partnership Volume and Value Trend (2019 – YTD*2023)

Figure 7: STADA Arzneimittel AG: Partnership Trend by Deal Type (2019 – YTD*2023)

Figure 8: STADA Arzneimittel AG: Divestments Volume and Value Trend (2019 – YTD*2023)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports